Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 September 2018
Soccer ladies relish challenge in Potch
Trinity Melakeco (right) in action for the Kovsie women’s soccer team against the Tshwane University of Technology (TUT) last year. They will face TUT, the defending champions, on Friday 21 September in Varsity Women’s Football.

The Kovsie women’s soccer team has a tough challenge ahead of them in their quest to reach the semi-finals of Varsity Women’s Football for the first time.

The tournament starts on Thursday 20 September 2018 in Potchefstroom. The Kovsies’ best performance in the competition was in 2016, when they were fifth.

They are in the same group as the University of Johannesburg (UJ), the University of KwaZulu-Natal (UKZN), and Tshwane University of Technology (TUT). TUT has dominated Varsity Women's Football, winning four of the five tournaments. TUT and UJ contested the final last year, as well as the University Sport South Africa (USSA) tournament in July.

Kovsie coach, Godfrey Tenoff, says the challenge of playing the top-seeds is one they relish and welcome.

According to him, the ladies will have gained confidence from USSA where they ended sixth, improving by two places from 2017.

“We were satisfied with our performance at USSA. There are so much the players are capable of, but they don’t get the platform to test their talents as often as the men. We only play UJ and TUT once or twice a year, and there are very few teams in our province with that much talent. So, we have to get out more and find opportunities to play against top-teams to put our preparations and methods to the test.”

“We’ve had a good defence all season, led by our captain, Uma Jakalase. This will have to get us through the tournament.”

* The fixtures: 20 Sept vs UKZN; 21 Sept vs. TUT and UJ. The play-off matches are scheduled for Saturday.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept